24 results
DEFM14A
KRTX
Karuna Therapeutics Inc
5 Feb 24
Proxy related to merger
4:12pm
. Pursuant to an engagement letter between Karuna and Goldman Sachs, Karuna has agreed to pay Goldman Sachs a transaction fee of approximately $117 … to representatives of counsel to Party A and representatives of Covington.
Also on December 20, 2023, Karuna entered into an engagement letter with Goldman Sachs
PREM14A
KRTX
Karuna Therapeutics Inc
22 Jan 24
Preliminary proxy related to merger
6:05am
with respect to the merger or any other matter. Pursuant to an engagement letter between Karuna and Goldman Sachs, Karuna has agreed to pay Goldman … on December 20, 2023, Karuna entered into an engagement letter with Goldman Sachs in connection with the proposed transaction.
In the afternoon
DEFA14A
KRTX
Karuna Therapeutics Inc
22 Dec 23
Additional proxy soliciting materials
5:20pm
of this Agreement, the Company has made available to Parent a true and complete copy of the engagement letter between the Company and the Financial
8-K
EX-2.1
n9ykt
22 Dec 23
Entry into a Material Definitive Agreement
5:07pm
S-3ASR
EX-1.2
4jmp8qb8qvphwahe o4b
21 Jun 23
Automatic shelf registration
5:15pm
8-K
EX-1.1
kwo9tyai2izi6o jiox6
11 Aug 22
Karuna Therapeutics Announces Proposed Public Offering of Common Stock
5:03pm
8-K
EX-99.1
sv0e0cm7giygist vg
10 Mar 21
Entry into a Material Definitive Agreement
4:47pm
8-K
EX-1.1
e0uodld6kr9v
3 Mar 21
Karuna Announces Proposed Public Offering of Common Stock
5:10pm
S-3ASR
EX-1.2
kediiev0v6zmdupix
2 Jul 20
Automatic shelf registration
4:19pm
DEF 14A
5ym1zphv9w72a3
29 Apr 20
Definitive proxy
4:00pm
S-1
EX-10.13
bdhak o3w0xd65m
31 May 19
IPO registration
4:03pm
S-1
EX-10.18
gk45lk0iyp25
31 May 19
IPO registration
4:03pm